Review of patient-reported outcomes in multiple myeloma registrational trials: highlighting areas for improvement
Abstract Over the past 13 years, there have been advances in characterizing the patient experience in oncology trials, primarily using patient-reported outcomes (PROs). This review aims to provide details on the PRO measures and analyses used in multiple myeloma (MM) registrational trials. We identi...
Main Authors: | Laura L. Fernandes, Jiaxi Zhou, Bindu Kanapuru, Erica Horodniceanu, Thomas Gwise, Paul G. Kluetz, Vishal Bhatnagar |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-08-01
|
Series: | Blood Cancer Journal |
Online Access: | https://doi.org/10.1038/s41408-021-00543-y |
Similar Items
-
The molecular make up of smoldering myeloma highlights the evolutionary pathways leading to multiple myeloma
by: Eileen M. Boyle, et al.
Published: (2021-01-01) -
Therapeutic outcome of early-phase clinical trials in multiple myeloma: a meta-analysis
by: Niels van Nieuwenhuijzen, et al.
Published: (2021-03-01) -
Long-term Outcomes in Patients With Multiple Myeloma
by: Silvia G.R. Verelst, et al.
Published: (2018-08-01) -
Recent updates on CAR T clinical trials for multiple myeloma
by: Quande Lin, et al.
Published: (2019-11-01) -
Multiple myeloma
by: Larisa P. Mendeleeva, et al.
Published: (2021-02-01)